home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Calibration in the FDA Regulated Industry

 
  December 01, 2009  
     
 
CfPA - The Center for Professional Advancement, New Brunswick, NJ
January 25-26, 2010


Who Should Attend
This overview course is intended for individuals in all industries, but specifically individuals in FDA regulated industries, who are responsible for establishing, maintaining and operating a calibration program and audit of calibration activities, including:

    • Quality Assurance
    • Quality Control
    • Quality Engineering
    • Technical Support
    • Research and Development
    • Facilities and Equipment Maintenance

Description
The regulations covering manufacture and control of drug products and medical devices require that firms have a program for the calibration of test and measurement equipment. A requirement for calibration is also defined in ISO 9000 and a Quality System for a calibration laboratory is described in ISO 17025. Calibration is a good business and science practice followed in all industries that require measurements for process monitoring and control. The program must include the elements of: calibration intervals, scheduling, specific calibration procedures, limits of accuracy and precision and remedial action in the event that the instrument does not meet established requirements.

This course addresses the regulatory and business requirements for calibration as an element of a Quality System and how these requirements support the increasing application of process monitoring and sophisticated laboratory instrumentation, along with the maturing discipline of calibration in the regulated industries. It includes a discussion of a compliant calibration program and concludes with a discussion of a model calibration procedure.

 
 
Organized by: CfPA - The Center for Professional Advancement
Invited Speakers: Dr. Jerry Lanese; President, The Lanese Group, Inc.
and
Joseph T. Busfield; Principal, Pharmaceutical Technical Services

 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: info@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.